Gallant Pet, Inc. is headquartered in San Diego, California, and operates in the pet healthcare sector, working with stem cell therapies and related services.
Subscribe to see Gallant Pet, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Gallant Pet, Inc. is a health & life sciences company headquartered in San Diego, United States. It has raised at least $57.6M across the 4 funding rounds on record. Its most recent funding round raised $10.2M in June 2025. Xcout tracks 15 named people at Gallant Pet, Inc., including Linda Black (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
9 more named people on record for Gallant Pet, Inc., with roles, board committees and tenure — see the full roster →
At least $57.6M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10.2M | — | |
| Series B | $15M | 5 named | |
| SEC Form D filing | $25.5M | — | |
| SEC Form D filing | $7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Gallant Pet, Inc.'s closest competitors — see the full list of competitors and alternatives →
PetDx, Inc. is a San Diego, California-based biotechnology research company specializing in molecular diagnostics and genomic testing for pets.
Coneksis is a biotechnology research company headquartered in San Diego, California, that specializes in veterinary health and therapeutics. The company was spun out of NantKwest in 2015 to focus on veterinary oncology, utilizing exclusive licenses for cell lines to develop treatments for conditions such as canine lymphoma.
Rejuvenate Bio, Inc. is a biotechnology company founded in 2019 and headquartered in San Diego, United States, specializing in innovative gene therapy applications.
Curelab Veterinary Inc. is a biotechnology company headquartered in Boston, Massachusetts, devoted to developing innovative veterinary therapeutics and treatments to help pets combat cancer and live longer lives.
PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications. Founded in 2009, PetVivo Holdings, Inc. maintains its corporate headquarters in Minneapolis, Minnesota.
Loyal is a biotechnology company developing longevity medications designed to extend the healthspan and lifespan of dogs by targeting the underlying biological processes of aging. The company provides veterinary professionals with clinical resources, education, and trial opportunities while offering dog owners information on senior canine care and aging.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Gallant Pet, Inc.? Suggest a correction · Work at Gallant Pet, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.